Kolexia
Petit Paul-Remi
Pharmacien
Hôpital La Timone
Marseille, France
40 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Surcharge en fer Nodule thyroïdien Thalassémie Hépatite Hépatite B Hémochromatose Tumeurs de la thyroïde Cardiomyopathies

Industries

VIATRIS SANTE
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Outbreak of adenovirus D8 in a neonatal intensive care unit involving multiple simultaneous transmission pathways.
The Journal of hospital infection   26 juillet 2023
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
Microorganisms   12 août 2022
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.
EBioMedicine   11 juillet 2022
A new strategy to count and sort neutrophil-derived extracellular vesicles: Validation in infectious disorders.
Journal of extracellular vesicles   04 avril 2022
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model.
Communications biology   10 mars 2022
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.
Antiviral research   24 novembre 2021
159 New Strategy to Improve the Detection of Large Neutrophil-derived Extracellular Vesicles in Plasma by Fluo-sensitive Flow Cytometry
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Investigation of Bufavirus and Parvovirus 4 in Patients with Gastro-Enteritis from the South-East of France.
Pathogens (Basel, Switzerland)   07 septembre 2021
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.
Antiviral research   12 juillet 2021
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Nature communications   19 mars 2021